The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient
Open accessAbstract
PURPOSE: Conventional wisdom has rendered patients with brain metastases ineligible for clinical trials for fear that poor survival could mask the benefit of otherwise promising treatments. Our group previously published the diagnosis-specific Graded Prognostic Assessment (GPA). Updates with larger contemporary cohorts using molecular markers and newly identified prognostic factors have been published. The purposes of this work are to present all the updated indices in a single report to guide treatment choice, stratify research, and define an eligibility quotient to expand eligibility. METHODS: A multi-institutional database of 6,984 patients with newly diagnosed brain metastases underwent multivariable analyses of prognostic factors and treatments associated with survival for each primary site. Significant factors were used to define the updated GPA. GPAs of 4.0 and 0.0 correlate with the best and worst prognoses, respectively. RESULTS: Significant prognostic factors varied by diagnosis and new prognostic factors were identified. Those factors were incorporated into the updated GPA with robust separation ( P < .01) between subgroups. Survival has improved, but varies widely by GPA for patients with non–small-cell lung, breast, melanoma, GI, and renal cancer with brain metastases from 7-47 months, 3-36 months, 5-34 months, 3-17 months, and 4-35 months, respectively. CONCLUSION: Median survival varies widely and our ability to estimate survival for patients with brain metastases has improved. The updated GPA (available free at brainmetgpa.com) provides an accurate tool with which to estimate survival, individualize treatment, and stratify clinical trials. Instead of excluding patients with brain metastases, enrollment should be encouraged and those trials should be stratified by the GPA to ensure those trials make appropriate comparisons. Furthermore, we recommend the expansion of eligibility to allow for the enrollment of patients with previously treated brain metastases who have a 50% or greater probability of an additional year of survival (eligibility quotient > 0.50).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
Patchell, R. A., Tibbs, P. A., Walsh, J. W., Dempsey, R. J., Maruyama, Y., Kryscio, R. J., Markesbery, W. R., Macdonald, J. S., & Young, B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002223220802 · Cited by 3,135
Chang, E. L., Wefel, J. S., Hess, K. R., Allen, P. K., Lang, F. F., Kornguth, D. G., Arbuckle, R. B., Swint, J. M., Shiu, A. S., Maor, M. H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70263-3 · Cited by 2,475
Andrews, D. W., Scott, C. B., Sperduto, P. W., Flanders, A. E., Gaspar, L. E., Schell, M. C., Werner-Wasik, M., Demas, W., Ryu, J., Bahary, J.-P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16250-8 · Cited by 2,417
Self-citationAoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., Kenjyo, M., Oya, N., Hirota, S., Shioura, H., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2483 · Cited by 2,213
Self-citationKocher, M., Soffietti, R., Abacioglu, U., Villà, S., Fauchon, F., Baumert, B. G., Fariselli, L., Tzuk-Shina, T., Kortmann, R.-D., Carrie, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1655 · Cited by 1,988
Brown, P. D., Jaeckle, K., Ballman, K. V., Farace, E., Cerhan, J. H., Anderson, S. K., Carrero, X. W., Barker, F. G., Deming, R., Burri, S. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.9839 · Cited by 1,671
Self-citationSperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0527 · Cited by 1,425 · cited 2×
“100 184 (7) 23 (12-42) 94 (6) 25 (12-49) 57 (9) 14 (7-33) 62 (9) 28 (10-102) 110 (13) 17 (8-42) 55 (7) 16 (7-26)”
Self-citationTucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer
Murthy, R. K., Loi, S., Okines, A., Paplomata, E., Hamilton, E., Hurvitz, S. A., Lin, N. U., Borges, V., Abramson, V., Anders, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1914609 · Cited by 1,326
Self-citationCombined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
Tawbi, H. A., Forsyth, P. A., Algazi, A., Hamid, O., Hodi, F. S., Moschos, S. J., Khushalani, N. I., Lewis, K., Lao, C. D., Postow, M. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805453 · Cited by 1,321
Sperduto, P. W., Berkey, B., Gaspar, L. E., Mehta, M., & Curran, W. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031
Self-citationLong, G. V., Atkinson, V., Lo, S., Sandhu, S., Guminski, A. D., Brown, M. P., Wilmott, J. S., Edwards, J., Gonzalez, M., Scolyer, R. A., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30139-6 · Cited by 987
Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J., Roberge, D., Bhatt, A., Jensen, A. W., Brown, P. D., Shih, H., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 985
Self-citationBrain metastases: epidemiology and pathophysiology
Gavrilovic, I. T., & Posner, J. B. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-8093-6 · Cited by 975
Mulvenna, P., Nankivell, M., Barton, R., Faivre-Finn, C., Wilson, P., McColl, E., Moore, B., Brisbane, I., Ardron, D., Holt, T., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30825-x · Cited by 711
Sperduto, P. W., Yang, T. J., Beal, K., Pan, H., Brown, P. D., Bangdiwala, A., Shanley, R., Yeh, N., Gaspar, L. E., Braunstein, S., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.3834 · Cited by 659
Self-citationLin, N. U., Diéras, V., Paul, D., Lossignol, D., Christodoulou, C., Stemmler, H.-J., Roché, H., Liu, M. C., Greil, R., Ciruelos, E., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1080 · Cited by 658
Self-citationTsao, M. N., Rades, D., Wirth, A., Lo, S. S., Danielson, B. L., Gaspar, L. E., Sperduto, P. W., Vogelbaum, M. A., Radawski, J. D., Wang, J. Z., et al. (2012) · Practical Radiation Oncology · doi:10.1016/j.prro.2011.12.004 · Cited by 587
Self-citationWu, Y.-L., Ahn, M.-J., Garassino, M. C., Han, J.-Y., Katakami, N., Kim, H. R., Hodge, R., Kaur, P., Brown, A. P., Ghiorghiu, D., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.77.9363 · Cited by 517
Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.027 · Cited by 371
Self-citationFreedman, R. A., Gelman, R. S., Anders, C. K., Melisko, M. E., Parsons, H. A., Cropp, A. M., Silvestri, K., Cotter, C. M., Componeschi, K. P., Marte, J. M., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01511 · Cited by 341
Self-citationBrain Metastases in Newly Diagnosed Breast Cancer: A Population-Based Study
Martin, A. M., Cagney, D. N., Catalano, P. J., Warren, L. E., Bellon, J. R., Punglia, R. S., Claus, E. B., Lee, E. Q., Wen, P. Y., Haas-Kogan, D. A., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0001 · Cited by 301
Self-citationSperduto, P. W., Wang, M., Robins, H. I., Schell, M. C., Werner-Wasik, M., Komaki, R., Souhami, L., Buyyounouski, M. K., Khuntia, D., Demas, W., et al. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.11.042 · Cited by 274
Self-citationAoyama, H., Tago, M., & Shirato, H. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1145 · Cited by 220
Self-citationSperduto, P. W., Jiang, W., Brown, P. D., Braunstein, S., Sneed, P., Wattson, D. A., Shih, H. A., Bangdiwala, A., Shanley, R., Lockney, N. A., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.06.2454 · Cited by 212
Self-citationSperduto, P. W., Shanley, R., Luo, X., Andrews, D., Werner-Wasik, M., Valicenti, R., Bahary, J.-P., Souhami, L., Won, M., & Mehta, M. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.07.002 · Cited by 173
Self-citationSperduto, P. W., Mesko, S. M., Li, J., Cagney, D. N., Aizer, A. A., Lin, N., Nesbit, E. G., Kruser, T. J., Chan, J. W. S., Braunstein, S. E., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.01.051 · Cited by 153
Self-citationLin, N., Prowell, T. M., Tan, A. R., Kozak, M., Rosen, O., Amiri‐Kordestani, L., White, J. R., Sul, J., Perkins, L. M., Beal, K., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.0761 · Cited by 131
Self-citationCamidge, D. R., Lee, E. Q., Lin, N., Margolin, K. A., Ahluwalia, M. S., Bendszus, M., Chang, S. M., Dancey, J. E., de Vries, E. G. E., Harris, G. J., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30693-9 · Cited by 110
Self-citationRamakrishna, N. R., Temin, S., Chandarlapaty, S., Crews, J. R., Davidson, N. E., Esteva, F. J., Giordano, S. H., Kirshner, J. J., Krop, I. E., Levinson, J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.2713 · Cited by 106
Self-citationSperduto, P. W., Yang, J. T., Beal, K. P., Pan, H. Y., Brown, P. D., Bangdiwala, A. S., Shanley, R., Yeh, N., Gaspar, L. E., Braunstein, S. E., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.06.006 · Cited by 96
Self-citationChurilla, T. M., Ballman, K. V., Brown, P. D., Twohy, E. L., Jaeckle, K. A., Farace, E., Cerhan, J. H., Anderson, S. K., Carrero, X. W., Garces, Y. I., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.07.045 · Cited by 87
Self-citationSperduto, P. W., Mesko, S. M., Li, J., Cagney, D. N., Aizer, A. A., Lin, N., Nesbit, E. G., Kruser, T. J., Chan, J. W. S., Braunstein, S. E., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa025 · Cited by 86
Self-citationSperduto, P. W., Deegan, B. J., Li, J., Jethwa, K. R., Brown, P. D., Lockney, N. A., Beal, K. P., Rana, N., Attia, A. A., Tseng, C., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy099 · Cited by 72
Self-citationThe Prognostic Value of BRAF , C-KIT , and NRAS Mutations in Melanoma Patients With Brain Metastases
Sperduto, P. W., Jiang, W., Brown, P. D., Braunstein, S. E., Sneed, P. K., Wattson, D. A., Shih, H. A., Bangdiwala, A. S., Shanley, R., Lockney, N. A., et al. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.03.030 · Cited by 66
Self-citationSperduto, P. W., Fang, P., Li, J., Breen, W. G., Brown, P. D., Cagney, D. N., Aizer, A. A., Yu, J. B., Chiang, V., Jain, S. K., et al. (2019) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2019.06.007 · Cited by 48
Self-citationHarvey, R. D., Bruinooge, S. S., Chen, L., Garrett-Mayer, E. S., Rhodes, W., Stepanski, E. J., Uldrick, T. S., Ison, G., Khozin, S., Rubinstein, W. S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3857 · Cited by 47
Churilla, T. M., Handorf, E. R., Collette, S., Collette, L., Dong, Y., Aizer, A. A., Köcher, M., Soffietti, R., Alexander, B. M., & Weiss, S. E. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx332 · Cited by 41
Self-citationSperduto, P. W., Deegan, B. J., Li, J., Jethwa, K. R., Brown, P. D., Lockney, N. A., Beal, K. P., Rana, N., Attia, A. A., Tseng, C., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.04.006 · Cited by 28
Self-citationRoberge, D., Brown, P. D., Whitton, A. C., O’Callaghan, C. J., Leis, A. M., Greenspoon, J. N., Smith, G. L., Hu, J. J., Nichol, A., Winch, C., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00380 · Cited by 19
Self-citationSperduto, P. W., Fang, P., Li, J., Breen, W. G., Brown, P. D., Cagney, D. N., Aizer, A. A., Yu, J. B., Chiang, V., Jain, S. K., et al. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.011 · Cited by 13
Self-citation
Cited by
Epidemiology of brain metastases and leptomeningeal disease
Lamba, N., Wen, P. Y., & Aizer, A. A. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab101 · Cited by 406
Self-citation
Metadata
- Authors
- Sperduto, P. W., Mesko, S., Li, J., Cagney, D., Aizer, A., Lin, N. U., Nesbit, E., Kruser, T. J., Chan, J., Braunstein, S., Lee, J., Kirkpatrick, J. P., Breen, W., Brown, P. D., Shi, D., Shih, H. A., Soliman, H., Sahgal, A., Shanley, R., Sperduto, W. A., Lou, E., Everett, A., Boggs, D. H., Masucci, L., Roberge, D., Remick, J., Plichta, K., Buatti, J. M., Jain, S., Gaspar, L. E., Wu, C.-C., Wang, T. J. C., Bryant, J., Chuong, M., An, Y., Chiang, V., Nakano, T., Aoyama, H., & Mehta, M. P.
- Venue
- Journal of Clinical Oncology
- Published
- 2020-11-10
- Volume
- 38
- Issue
- 32
- Pages
- 3773-3784
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W3086164260
- Cited by
- 471
- References
- 40
- FWCI
- 26.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.